XML 23 R5.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Series C Convertible Preferred Stock [Member]
Convertible Preferred Stock [Member]
Convertible Preferred Stock [Member]
Series B And C Convertible Preferred Stock
Convertible Preferred Stock [Member]
Series B Convertible Preferred Stock [Member]
Convertible Preferred Stock [Member]
Series C Convertible Preferred Stock [Member]
Common Stock [Member]
Common Stock [Member]
Series B And C Convertible Preferred Stock
Common Stock [Member]
Series B Convertible Preferred Stock [Member]
Common Stock [Member]
Series C Convertible Preferred Stock [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Series C Convertible Preferred Stock [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Balance at Dec. 31, 2017 $ 13,000                   $ 413,362   $ 1,387 $ (401,749)
Balance (in shares) at Dec. 31, 2017     2,431       115,651              
Share-based compensation 355                   355      
Sale/Issuance of common stock 1,624 $ 3,041                 1,624 $ 3,041    
Sale/Issuance of common stock (in shares)           6,723 92,169              
Conversion of Convertible Preferred Stock into common stock   8                   8    
Conversion of Convertible Preferred Stock into common stock (share)         (1,320) (3,228)     7,921 80,868        
Beneficial conversion feature related to Series C Convertible Preferred Stock   2,487                   2,487    
Accretion of beneficial conversion feature related to Series C Convertible Preferred Stock   (2,487)                   (2,487)    
Foreign currency translation adjustment and accumulated other comprehensive income (169)                       (169)  
Net loss (12,634)                         (12,634)
Balance at Dec. 31, 2018 $ 5,225                   418,390   1,218 (414,383)
Balance (in shares) at Dec. 31, 2018 296,609   4,606       296,609              
Share-based compensation $ 127                   127      
Sale of common stock and pre-funded warrants, net of offering costs 4,421           $ 4       4,417      
Sale of common stock and pre-funded warrants, net of offering costs (in shares)             3,000,000              
Sale/Issuance of common stock 2,208                   2,208      
Sale/Issuance of common stock (in shares)             184,666              
Conversion of Convertible Preferred Stock into common stock (share)       (2,647)       334,199            
Exercise of warrants 490                   490      
Exercise of warrants (in shares)             65,114              
Warrant derivative liability reclasssifiedto equity due to exercise of warrants 794                   794      
Beneficial conversion feature related to Series C Convertible Preferred Stock   554                   554    
Accretion of beneficial conversion feature related to Series C Convertible Preferred Stock   $ (554)                   $ (554)    
Foreign currency translation adjustment and accumulated other comprehensive income (1,218)                       $ (1,218)  
Net loss (10,887)                         (10,887)
Balance at Dec. 31, 2019 $ 1,160           $ 4       $ 426,426     $ (425,270)
Balance (in shares) at Dec. 31, 2019 3,880,588   1,959       3,880,588